يعرض 1 - 20 نتائج من 44 نتيجة بحث عن '"Holger Thurm"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Institut Català de la Salut, [Mazieres J] Toulouse University Hospital, Toulouse, France. [Iadeluca L] Pfizer Inc, New York, NY, USA. [Shaw AT] Massachusetts General Hospital Cancer Center, Boston, MA, USA. [Solomon BJ] Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. [Bauer TM] Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA. [de Marinis F] European Institute of Oncology, IRCCS, Milan, Italy. [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  4. 4
  5. 5

    المصدر: Cancer Science

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    المصدر: Oral oncology. 115

  11. 11
  12. 12

    المساهمون: Institut Català de la Salut, [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shaw AT] Massachusetts General Hospital, Boston, USA. [Bearz A] National Institute for Cancer Research, Aviano, Italy. [Camidge DR] University of Colorado, Aurora, USA. [Solomon BJ] Peter MacCallum Cancer Centre, Melbourne, Australia. [Bauman JR] Fox Chase Cancer Center, Philadelphia, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Lactams, medicine.drug_class, medicine.medical_treatment, Lactams, Macrocyclic, Phases of clinical research, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Aminopyridines, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, medicine, Anaplastic lymphoma kinase, Humans, In patient, Other subheadings::/therapeutic use [Other subheadings], Lung cancer, Protein Kinase Inhibitors, Chemotherapy, business.industry, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], Otros calificadores::/uso terapéutico [Otros calificadores], Receptor Protein-Tyrosine Kinases, Hematology, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Lorlatinib, respiratory tract diseases, Proteïnes quinases - Inhibidors, 030104 developmental biology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Pyrazoles, business, Pulmons - Càncer - Tractament

    وصف الملف: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    المساهمون: Institut Català de la Salut, [Bauer TM, Johnson ML] Sarah Cannon Cancer Research Institute/Tennessee Oncology, PLLC, 250 25th Ave N, Nashville, TN 37203, USA. [Shaw AT, Gainor JF] Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA. [Navarro A, Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Thurm H] Pfzer Oncology, 10777 Science Center Dr, La Jolla, CA, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Targeted Oncology
    Scientia

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Phases of clinical research, Aminopyridines, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Tyrosine-kinase inhibitor, 0302 clinical medicine, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, Pharmacology (medical), Cumulative incidence, Original Research Article, Aged, 80 and over, Brain Neoplasms, Incidence, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], Middle Aged, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad [ENFERMEDADES], 030220 oncology & carcinogenesis, Disease Progression, Female, medicine.drug, Adult, medicine.medical_specialty, Lactams, medicine.drug_class, Lactams, Macrocyclic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], 03 medical and health sciences, Internal medicine, medicine, ROS1, Humans, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [DISEASES], Lung cancer, Aged, Crizotinib, business.industry, neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Lorlatinib, respiratory tract diseases, 030104 developmental biology, Avaluació de resultats (Assistència sanitària), Pyrazoles, business, Pulmons - Càncer - Tractament, Progressive disease

    وصف الملف: application/pdf

  18. 18
  19. 19
  20. 20